NEU Stock Analysis: NewMarket | NYSE
Specialty Chemicals | NYSE, USA | Market Cap: 8.518m USD | 12M Return: 15.7% | US6515871076 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 111M
EPS Trend: -22.3%
Rev. Trend: 13.8%
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
NewMarket Corporation (NYSE: NEU) is a U.S.-based specialty chemicals company that primarily manufactures and sells petroleum additives through its subsidiaries. Its product portfolio covers lubricant additives (engine oils, transmission fluids, gear and hydraulic oils), engine oil additives for passenger and heavy-duty applications, driveline additives, industrial additives, and fuel additives designed to improve refining efficiency and fuel performance. The company also markets antiknock compounds, performs contract manufacturing, and owns a real property in Virginia. NewMarket sells to industrial customers, government entities, OEMs, and individual buyers across North America, Latin America, Asia Pacific, Europe, the Middle East, Africa, and India.
Founded in 1887 and headquartered in Richmond, Virginia, NewMarket has been publicly traded since its 1985 IPO. The petroleum additives industry is a specialized segment of the broader specialty chemicals market, supplying formulated chemical packages that are blended into base oils and fuels by refiners and lubricant blenders. Because additive formulations are typically tailored to customer specifications and engine or equipment requirements, the business model relies on long-standing technical relationships with oil majors, OEMs, and industrial lubricant marketers, which tends to create high switching costs and recurring revenue.
- Lubricant additive demand rises on stricter global emissions standards
- Petroleum feedstock costs pressure specialty chemical margins
- International sales expose results to Asia and Europe FX swings
| Net Income: 433.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA -2.67 > 1.0 |
| NWC/Revenue: 23.32% < 20% (prev 23.96%; Δ -0.63% < -1%) |
| CFO/TA 0.17 > 3% & CFO 598.8m > Net Income 433.4m |
| Net Debt (931.4m) to EBITDA (671.4m): 1.39 < 3 |
| Current Ratio: 2.25 > 1.5 & < 3 |
| Outstanding Shares: last quarter (9.40m) vs 12m ago 0.02% < -2% |
| Gross Margin: 31.49% > 18% (prev 32.69%; Δ -1.20% > 0.5%) |
| Asset Turnover: 80.48% > 50% (prev 86.99%; Δ -6.52% > 0%) |
| Interest Coverage Ratio: 16.92 > 6 (EBIT TTM 606.6m / Interest Expense TTM 35.8m) |
| A: 0.18 (Total Current Assets 1.15b - Total Current Liabilities 510.8m) / Total Assets 3.62b |
| B: 0.48 (Retained Earnings 1.74b / Total Assets 3.62b) |
| C: 0.18 (EBIT TTM 606.6m / Avg Total Assets 3.41b) |
| D: 1.03 (Book Value of Equity 1.84b / Total Liabilities 1.78b) |
| Altman-Z'' = 5.00 = AAA |
| DSRI: 1.07 (Receivables 480.7m/453.7m, Revenue 2.74b/2.78b) |
| GMI: 1.04 (GM 32.69% / 31.49%) |
| AQI: 1.07 (AQ_t 0.44 / AQ_t-1 0.41) |
| SGI: 0.99 (Revenue 2.74b / 2.78b) |
| TATA: -0.05 (NI 433.4m - CFO 598.8m) / TA 3.62b) |
| Beneish M = -2.90 (Cap -4..+1) = A |
As of October 14, 2026, the stock is trading at USD 898.98 with a total of 113,193 shares traded. Over the past week, the price has changed by -2.95%, over one month by +2.45%, over three months by +19.13% and over the past year by +15.65%.
Current recommended Stop Loss: 872.60 (which is 2.9% or 1.2 ATR below the current price).
NewMarket has no consensus analysts rating.
| Analysts Target Price | 450 | -49.9% |
P/E Trailing = 19.9329
P/E Forward = 22.5225
P/S = 3.1061
P/B = 4.4462
P/EG = 5.6368
Revenue TTM = 2.74b USD
EBIT TTM = 606.6m USD
EBITDA TTM = 671.4m USD
Long Term Debt = 854.8m USD (from longTermDebt, last quarter)
Short Term Debt = 18.0m USD (from shortTermDebt, last quarter)
Debt = 1.03b USD (from shortLongTermDebtTotal, last quarter) + Leases 85.1m
Net Debt = 931.4m USD (calculated: Debt 1.03b - CCE 93.6m)
Enterprise Value = 9.45b USD (8.52b + Debt 1.03b - CCE 93.6m)
Interest Coverage Ratio = 16.92 (Ebit TTM 606.6m / Interest Expense TTM 35.8m)
EV/FCF = 18.95x (Enterprise Value 9.45b / FCF TTM 498.7m)
FCF Yield = 5.28% (FCF TTM 498.7m / Enterprise Value 9.45b)
FCF Margin = 18.18% (FCF TTM 498.7m / Revenue TTM 2.74b)
Net Margin = 15.80% (Net Income TTM 433.4m / Revenue TTM 2.74b)
Gross Margin = 31.49% ((Revenue TTM 2.74b - Cost of Revenue TTM 1.88b) / Revenue TTM)
Gross Margin QoQ = 32.45% (prev 32.98%)
Tobins Q-Ratio = 2.61 (Enterprise Value 9.45b / Total Assets 3.62b)
Interest Expense / Debt = 3.50% (Interest Expense 35.8m / Debt 1.03b)
Taxrate = 24.07% (137.4m / 570.8m)
NOPAT = 460.6m (EBIT 606.6m * (1 - 24.07%))
Current Ratio = 2.25 (Total Current Assets 1.15b / Total Current Liabilities 510.8m)
Debt / Equity = 0.56 (Debt 1.03b / totalStockholderEquity, last quarter 1.84b)
Debt / EBITDA = 1.39 (Net Debt 931.4m / EBITDA 671.4m)
Debt / FCF = 1.87 (Net Debt 931.4m / FCF TTM 498.7m)
Total Stockholder Equity = 1.76b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.72% (Net Income 433.4m / Total Assets 3.62b)
RoE = 24.63% (Net Income TTM 433.4m / Total Stockholder Equity 1.76b)
RoCE = 23.20% (EBIT 606.6m / Capital Employed (Equity 1.76b + L.T.Debt 854.8m))
RoIC = 15.18% (NOPAT 460.6m / Invested Capital 3.03b)
WACC = 7.38% (E(8.52b)/V(9.54b) * Re(7.95%) + D(1.03b)/V(9.54b) * Rd(3.50%) * (1-Tc(0.24)))
Discount Rate = 7.95% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -86.83 | Cagr: -0.75%
[DCF] Terminal Value 74.73% ; FCFF base≈509.2m ; Y1≈489.8m ; Y5≈476.1m
[DCF] Fair Price = 711.5 (EV 7.47b - Net Debt 931.4m = Equity 6.54b / Shares 9.20m; r=8.35% [WACC [floored]]; 5y FCF grow -5.03% → 2.50% )
EPS Correlation: -22.29 | EPS CAGR: -2.79% | SUE: N/A | # QB: 0
Revenue Correlation: 13.80 | Revenue CAGR: 0.20% | SUE: N/A | # QB: 0